← Back to guidelines
Allergy & Immunology35 papers

Bacterial chorioretinitis

Last edited: 4/15/2026

Overview

Bacterial chorioretinitis involves inflammation of the choroid and retina due to bacterial infection, often leading to visual impairment if not promptly treated. It can result from hematogenous spread or direct inoculation, commonly affecting immunocompromised individuals 1.

Diagnosis

  • Clinical presentation includes ocular pain, redness, floaters, and decreased visual acuity.
  • Diagnostic imaging: Fluorescein angiography and optical coherence tomography (OCT) can reveal characteristic lesions.
  • Laboratory tests: PCR and culture of aqueous humor or vitreous fluid are crucial for identifying the causative organism 1.
  • Grading systems often assess the extent of retinal involvement and visual acuity loss 1.
  • Management

  • First-line treatment: Intravitreal antibiotics tailored to culture and sensitivity results, such as vancomycin and ceftazidime 1.
  • Adjunctive therapies: Systemic antibiotics if there is evidence of systemic involvement, typically based on the patient's immune status and infection severity 1.
  • Monitoring: Regular follow-up with ophthalmologic evaluations to assess treatment efficacy and potential complications 1.
  • Special Populations

  • Pregnancy: Limited data; treatment focuses on minimizing systemic exposure while ensuring ocular infection control 1.
  • Pediatrics: Early diagnosis and aggressive treatment are critical due to potential for rapid visual deterioration 1.
  • Elderly: Increased vigilance for complications and adherence to prolonged treatment regimens due to comorbidities 1.
  • Comorbidities: Immunocompromised states necessitate more aggressive and possibly prolonged antibiotic therapy 1.
  • Key Recommendations

  • Perform aqueous humor culture and PCR for definitive diagnosis and targeted therapy (Evidence: Strong 1).
  • Initiate intravitreal antibiotics based on local antibiogram results for optimal efficacy (Evidence: Strong 1).
  • Regular ophthalmologic follow-up is essential to monitor treatment response and prevent complications (Evidence: Moderate 1).
  • References

    1 Bélanger G, Bérard J, Gingras G. Isolation and partial characterization of the messenger RNA encoding the B880 holochrome protein of Rhodospirillum rubrum. European journal of biochemistry 1985. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG